• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过应用显示省略对象的决策分析模型(DAMWOOD)来提高决策模型的透明度。

Improving Transparency of Decision Models Through the Application of Decision Analytic Models with Omitted Objects Displayed (DAMWOOD).

机构信息

Institute of Health Economics, Edmonton, Canada.

Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada.

出版信息

Pharmacoeconomics. 2024 Nov;42(11):1197-1208. doi: 10.1007/s40273-024-01401-y. Epub 2024 Aug 7.

DOI:10.1007/s40273-024-01401-y
PMID:39110389
Abstract

The coronavirus disease 2019 (COVID-19) pandemic has increased public awareness of the influence of epidemiological and economic decision models on public policy decisions. Alongside this is an increased scrutiny on the development, analysis, reporting and utilisation of decision models for public policy making. Therefore, it is important that model developers can clearly explain and justify to all stakeholders what is included and excluded from a model developed to support decision-making, to both improve transparency and trust in decision-making. Our aim is to provide tools for improving communication between modellers and decision-makers, leading to improved transparency in decision-making. To do so, we extend the recently described directed acyclic graphs with omitted objects displayed (DAGWOOD) approach from Haber et al. (Ann Epidemiol 68:64-71, 2022) to decision analytic models, giving the decision analytic models with omitted objects displayed (DAMWOOD) approach. DAMWOOD is a framework for the identification of objects omitted from a decision model, as well as for consideration of the effects of omissions on model outcomes. Objects omitted from a decision model are classed as either an exclusion (known and unknown confounders), misdirection (alternative model pathways) or structure (e.g. model type, methods for estimating relationships between objects). DAMWOOD requires model developers to use explicit statements and provide illustration of included and omitted objects, supporting communication with model users and stakeholders, allowing them to provide input and feedback to modellers about which objects to include or omit in a model. In developing DAMWOOD, we considered two challenges we encountered in modelling for pandemic policy response. First, the scope of the decision problem is not always made sufficiently explicit by decision-makers, requiring modellers to intuit which policy options should be considered, and/or which outcomes should be considered in their evaluation. Second, there is rarely sufficient transparency to ensure stakeholders can see what is included in models and why. This limits stakeholders' ability to advocate to decision-makers for the prioritisation of specific outcomes and challenge the model results. To illustrate the application of DAMWOOD, we apply it to a previously published COVID-19 vaccine allocation optimisation model. The DAMWOOD diagrams illustrate the ways in which it is possible to improve the communication of model assumptions. The diagrams make explicit which outcomes are omitted and provide information on the expected impact of the omissions on model results. We discuss the usefulness of DAMWOOD for framing the decision problem, communicating the model structure and results and engaging with those making and affected by the decisions the model is developed to inform.

摘要

2019 年冠状病毒病(COVID-19)大流行提高了公众对流行病学和经济决策模型对公共政策决策影响的认识。与此同时,对用于公共政策制定的决策模型的开发、分析、报告和利用也进行了更严格的审查。因此,模型开发人员能够向所有利益相关者清楚地解释和说明从模型中排除和包含的内容,这一点非常重要,这有助于提高决策的透明度和信任度。我们的目标是提供工具,以改善建模者和决策者之间的沟通,从而提高决策的透明度。为此,我们扩展了 Haber 等人最近描述的带有省略对象的有向无环图(DAGWOOD)方法(Ann Epidemiol 68:64-71, 2022),以用于决策分析模型,从而得到带有省略对象的决策分析模型(DAMWOOD)方法。DAMWOOD 是一种用于识别从决策模型中省略的对象的框架,以及用于考虑省略对模型结果的影响的框架。从决策模型中省略的对象分为排除项(已知和未知的混杂因素)、误导项(替代模型途径)或结构(例如模型类型、用于估计对象之间关系的方法)。DAMWOOD 要求模型开发人员使用明确的语句并提供包含和省略对象的说明,这有助于与模型用户和利益相关者进行沟通,允许他们向建模人员提供有关在模型中包含或省略哪些对象的输入和反馈。在开发 DAMWOOD 时,我们考虑了在大流行政策应对建模中遇到的两个挑战。首先,决策者并未充分明确说明决策问题的范围,这要求建模人员凭直觉来确定应考虑哪些政策选项,以及/或者在评估中应考虑哪些结果。其次,很少有足够的透明度来确保利益相关者能够看到模型中包含的内容以及原因。这限制了利益相关者为决策者争取特定结果的优先级并对模型结果提出质疑的能力。为了说明 DAMWOOD 的应用,我们将其应用于之前发表的 COVID-19 疫苗分配优化模型。DAMWOOD 图说明了可以改善模型假设沟通的方式。这些图明确了省略了哪些结果,并提供了有关省略对模型结果影响的信息。我们讨论了 DAMWOOD 用于构建决策问题、沟通模型结构和结果以及与制定和受模型决策影响的人员进行互动的有用性。

相似文献

1
Improving Transparency of Decision Models Through the Application of Decision Analytic Models with Omitted Objects Displayed (DAMWOOD).通过应用显示省略对象的决策分析模型(DAMWOOD)来提高决策模型的透明度。
Pharmacoeconomics. 2024 Nov;42(11):1197-1208. doi: 10.1007/s40273-024-01401-y. Epub 2024 Aug 7.
2
Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.避免和识别健康技术评估模型中的错误:定性研究和方法学综述。
Health Technol Assess. 2010 May;14(25):iii-iv, ix-xii, 1-107. doi: 10.3310/hta14250.
3
The use of evidence to guide decision-making during the COVID-19 pandemic: divergent perspectives from a qualitative case study in British Columbia, Canada.利用证据在 COVID-19 大流行期间指导决策:来自加拿大不列颠哥伦比亚省的定性案例研究的不同观点。
Health Res Policy Syst. 2024 Jun 3;22(1):66. doi: 10.1186/s12961-024-01146-2.
4
A health technology assessment of COVID-19 vaccination for Nigerian decision-makers: Identifying stakeholders and pathways to support evidence uptake.尼日利亚决策者的 COVID-19 疫苗接种卫生技术评估:确定利益相关者和支持证据采用的途径。
Health Res Policy Syst. 2024 Jun 26;22(1):73. doi: 10.1186/s12961-024-01158-y.
5
Public participation in decisions about measures to manage the COVID-19 pandemic: a systematic review.公众参与管理 COVID-19 大流行措施决策:系统评价。
BMJ Glob Health. 2024 Jun 3;9(6):e014404. doi: 10.1136/bmjgh-2023-014404.
6
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
7
Recalibrating the notion of modelling for policymaking during pandemics.在大流行期间重新校准政策制定中的建模概念。
Epidemics. 2022 Mar;38:100552. doi: 10.1016/j.epidem.2022.100552. Epub 2022 Mar 2.
8
DAG With Omitted Objects Displayed (DAGWOOD): a framework for revealing causal assumptions in DAGs.显示省略对象的有向无环图(DAGWOOD):一种揭示有向无环图中因果假设的框架。
Ann Epidemiol. 2022 Apr;68:64-71. doi: 10.1016/j.annepidem.2022.01.001. Epub 2022 Feb 3.
9
The GRADE Evidence to Decision (EtD) framework for health system and public health decisions.卫生系统和公共卫生决策中的 GRADE 证据决策(EtD)框架。
Health Res Policy Syst. 2018 May 29;16(1):45. doi: 10.1186/s12961-018-0320-2.
10
Causal evidence in health decision making: methodological approaches of causal inference and health decision science.健康决策中的因果证据:因果推断方法和健康决策科学。
Ger Med Sci. 2022 Dec 21;20:Doc12. doi: 10.3205/000314. eCollection 2022.

引用本文的文献

1
Health-economic evaluation of statins versus lifestyle changes for cardiovascular disease prevention.他汀类药物与生活方式改变对心血管疾病预防的卫生经济学评估。
PLoS One. 2025 Sep 12;20(9):e0331176. doi: 10.1371/journal.pone.0331176. eCollection 2025.

本文引用的文献

1
Reflections On Epidemiological Modeling To Inform Policy During The COVID-19 Pandemic In Western Europe, 2020-23.2020-2023 年西欧 COVID-19 大流行期间的流行病学建模对政策制定的启示的反思。
Health Aff (Millwood). 2023 Dec;42(12):1630-1636. doi: 10.1377/hlthaff.2023.00688.
2
The Epistemic Risk in Representation.代表性的认识风险。
Kennedy Inst Ethics J. 2022;32(1):1-31. doi: 10.1353/ken.2022.0001.
3
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations.
《2022年卫生经济评估报告合并标准》(CHEERS 2022)声明:卫生经济评估的更新报告指南。
Clin Ther. 2022 Feb;44(2):158-168. doi: 10.1016/j.clinthera.2022.01.011. Epub 2022 Feb 12.
4
DAG With Omitted Objects Displayed (DAGWOOD): a framework for revealing causal assumptions in DAGs.显示省略对象的有向无环图(DAGWOOD):一种揭示有向无环图中因果假设的框架。
Ann Epidemiol. 2022 Apr;68:64-71. doi: 10.1016/j.annepidem.2022.01.001. Epub 2022 Feb 3.
5
Value judgments in a COVID-19 vaccination model: A case study in the need for public involvement in health-oriented modelling.新冠疫苗接种模型中的价值判断:以需要公众参与以健康为导向的建模为例。
Soc Sci Med. 2021 Oct;286:114323. doi: 10.1016/j.socscimed.2021.114323. Epub 2021 Aug 18.
6
A Net Benefit Approach for the Optimal Allocation of a COVID-19 Vaccine.一种 COVID-19 疫苗最优分配的净收益方法。
Pharmacoeconomics. 2021 Sep;39(9):1059-1073. doi: 10.1007/s40273-021-01037-2. Epub 2021 Jun 17.
7
Health Economists on Involving Patients in Modeling: Potential Benefits, Harms, and Variables of Interest.卫生经济学家论患者参与建模:潜在获益、危害和关注变量。
Pharmacoeconomics. 2021 Jul;39(7):823-833. doi: 10.1007/s40273-021-01018-5. Epub 2021 May 7.
8
Social, ethical, and other value judgments in health economics modelling.健康经济学建模中的社会、伦理和其他价值判断。
Soc Sci Med. 2020 May;253:112975. doi: 10.1016/j.socscimed.2020.112975. Epub 2020 Apr 2.
9
Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--7.模型透明度和验证:ISPOR-SMDM 建模良好实践工作组的报告——7.
Value Health. 2012 Sep-Oct;15(6):843-50. doi: 10.1016/j.jval.2012.04.012.
10
Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting.使用决策分析模型的经济评估:设计、实施、分析与报告。
BMJ. 2011 Apr 11;342:d1766. doi: 10.1136/bmj.d1766.